Clinical Trial Update: Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the safety and immunogenicity of an investigational pentavalent meningococcal ABCYW vaccine in pediatric participants (children, to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Pentavalent meningococcal ABCYW vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Immunization, Healthy Volunteers | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING